3 Takeover Targets – Week of 2/18

Takeover deals can be a signal of positive market sentiment, indicating that the acquiring company is confident in its growth prospects and is willing to invest in expanding its market share. Such deals often lead to an increase in stock prices as they indicate potential value creation and synergies for the acquiring company. Takeover deals may provide an opportunity for investors to capitalize on market inefficiencies and earn profits through arbitrage strategies, such as buying the target company’s stock at a discount to the offer price and profiting from the price convergence upon deal completion.

Here are three takeover targets for the week –

Whole Earth Brands, Inc. – SYM: FREE
Recent Price: $4.75
Takeover Action: Whole Earth Brands, Inc. confirmed that the Company entered into a definitive agreement pursuant to which Ozark Holdings, LLC will acquire all of the outstanding shares of the Company’s common stock that it does not already own in an all-cash transaction for $4.875 per share.
Description: Whole Earth Brands, Inc. operates as a food company worldwide. It operates through two segments, Branded CPG and Flavors & Ingredients. The company was incorporated in 2020 and is based in Chicago, Illinois.

Biggest Investors in the World LOADING UP on This AI Stock

oxford chart

It’s a small cap that trades for less than $10… Yet the biggest investors in the world own millions of shares.

Why? Because their AI just did something no company has ever done before.

Details here.


CymaBay Therapeutics, Inc. – SYM: CBAY
Recent Price: $32.19
Takeover Action: Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion.
Description: CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of autoimmune liver disease, primary biliary cholangitis (PBC). The company also develops MBX-2982 for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.

7 Stocks to Own Before the 2024 Election

election book

The only thing that can be certain about the 2024 election cycle is another year of mudslinging and rancor among parties. What this means for investors is another year with potentially high volatility and uncertainty in the stock market. The only way to avoid the hassle is to be out of the market, which isn’t viable. Where should investors put their money? MarketBeat’s team of analysts have made a list of these stocks in a special report titled “7 Stocks to Own Before the 2024 Election.”

Click the link below to get your copy. FREE


VIZIO Holding Corp. – SYM: VZIO
Recent Price: $9.43
Takeover Action: According to WSJ, Walmart (WMT) is in talks to buy smart television-manufacturer Vizio (VZIO) for more than $2 billion.
Description: VIZIO Holding Corp., through its subsidiaries, provides smart televisions, sound bars, and accessories in the United States. It also operates Platform+ that comprises SmartCast, a Smart TV operating system, enabling integrated home entertainment solution, and data intelligence and services products through Inscape. Its SmartCast delivers content and applications through an easy-to-use interface, as well as supports streaming apps, such as Amazon Prime Video, Apple TV+, Discovery+, Disney+, HBO Max, Hulu, Netflix, Paramount+, Peacock, and YouTube TV and hosts its free ad-supported video app, WatchFree, and VIZIO Free channels. In addition, the company provides support for third-party voice platforms, including Amazon Alexa, Apple HomeKit, and Google Voice Assistant, as well as second screen viewing. It sells its products to retailers and through online channels. VIZIO Holding Corp. was incorporated in 2002 and is headquartered in Irvine, California.

There is a $1Trillion Opportunity in Investment Media

fintech tv

Watch this to see if you should own a piece of it…

Click here for the full story…

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.